Clear cell carcinomas were examined in 20.7% (n = 333) of the cases, with genomic alterations in ARID1A (n = 231, 69.4%) and PIK3CA (n = 190, 57.1%), consistent with previous reports [15] (Figure 2C). This evidence concerns the gene PIK3CA and clear cell adenocarcinoma.